Scholarly Works

Transition from apixaban to warfarin—addressing...

Journal article

Transition from apixaban to warfarin—addressing excess stroke, systemic embolism, and major bleeding

Authors

Cairns JA; Weitz JI

Journal

American Heart Journal, Vol. 169, No. 1, pp. 1–3

Publisher

Elsevier

Publication Date

January 1, 2015

DOI

10.1016/j.ahj.2014.09.007

ISSN

0002-8703

Associated Experts

Jeffrey Weitz

Professor, FHSMED

Labels

Fields of Research (FoR)

32 Biomedical and Clinical Sciences 3201 Cardiovascular medicine and haematology

Medical Subject Headings (MeSH)

Antithrombins Atrial Fibrillation Benzimidazoles Dabigatran Factor Xa Inhibitors Hemorrhage Humans International Normalized Ratio Morpholines Pyrazoles Pyridones Rivaroxaban Stroke Thiophenes Vitamin K Warfarin beta-Alanine

View published work (Non-McMaster Users)

View published work (McMaster Users)

Contact the Experts team

Get technical help

or

Provide website feedback